Novo Integrated Sciences, Inc.
NVOS
$0.065
$0.009316.70%
| 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | 08/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -6.74% | -4.28% | 24.02% | 13.80% | 140.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.74% | -4.28% | 24.02% | 13.80% | 140.56% |
| Cost of Revenue | -36.71% | 13.96% | 16.45% | 15.93% | 129.49% |
| Gross Profit | 69.95% | -31.75% | 36.38% | 11.76% | 1,103.46% |
| SG&A Expenses | -37.50% | 24.51% | 3.85% | 32.15% | -16.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -37.21% | 20.09% | 8.45% | 27.34% | 297.08% |
| Operating Income | 69.74% | -76.19% | 13.82% | -47.98% | 36.84% |
| Income Before Tax | 256.57% | -824.82% | 40.89% | -18.39% | 85.85% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 256.57% | -824.82% | 40.89% | -18.39% | 85.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -129.67% | 53.33% | -102.52% | -1,607.69% | -77.90% |
| Net Income | 258.25% | -817.78% | 40.58% | -18.93% | 85.91% |
| EBIT | 69.74% | -76.19% | 13.82% | -47.98% | 36.84% |
| EBITDA | 85.17% | -130.78% | 21.28% | -65.79% | 40.66% |
| EPS Basic | 223.83% | -605.08% | 73.27% | 75.93% | 97.07% |
| Normalized Basic EPS | 252.36% | -601.83% | 73.19% | 79.21% | 90.54% |
| EPS Diluted | 223.83% | -605.08% | 73.27% | 75.93% | 97.07% |
| Normalized Diluted EPS | 252.36% | -601.83% | 73.19% | 79.21% | 90.54% |
| Average Basic Shares Outstanding | 27.83% | 30.12% | 122.38% | 394.06% | 380.51% |
| Average Diluted Shares Outstanding | 27.83% | 30.12% | 122.38% | 394.06% | 380.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
